Get started
Author

Yutong Liu

Observed name: Liu, Yutong
Observed institution: Genesis Analytics (South Africa)
ORCID: 0009-0006-2205-2962
Observed ORCID: 0009-0006-2205-2962
OpenAlex ID: A5126164647
Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study
2026 · Robert G Gish, Joanna P MacEwan, et al. · Journal of Comparative Effectiveness Research · 1
Supplementary Figure 1 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 6 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary figure 5 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Table 1 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Table 2 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 2 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 3 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Table 3 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 4 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary data: Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study
2026 · Gish, Robert, P MacEwan, Joanna, et al. · Figshare
Supplementary Figure 6 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary figure 5 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Table 1 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 4 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Data from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Table 3 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 1 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Table 2 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 3 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Supplementary Figure 2 from Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation
2026 · Shiqi Yin, Yutong Liu, et al.
Works count: 21
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type